Palatin Technologies Q2 Loss Narrower Than Estimate – Quick Facts

Biopharmaceutical company Palatin Technologies, Inc. (PTN) on Tuesday reported a net loss of $5.04 million or $0.02 per share for the second quarter, compared to net income of $3.03 million, or $0.01 per share in the prior-year quarter.

There were no revenues recorded in the quarter

On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.03 per share on revenues of $400,000 for the quarter. Analysts’ estimates typically exclude special items.

The company decreased debt and related liabilities to $2.8 million at December 31, 2018 from $7.2 million at June 30, 2018.

Source: Read Full Article